The Ministry of Health has decided to temporarily stop the distribution and use of AstraZeneca vaccine Batch CTMAV547 totaling 448.480 doses.
“This is a form of government caution to ensure the safety of this vaccine. The Ministry of Health urges the public to be calm and not be consumed by hoaxes circulating. The public is expected to always access information from reliable sources,” said Ministry of Health spokesperson Siti Nadia Tarmizi, Sunday (16/5/2021) afternoon.
Not all batches of AstraZeneca vaccines were stopped for distribution and use. Only Batch CTMAV547 is temporarily suspended while waiting for the results of the investigation and testing which may take one to two weeks.
Batch CTMAV547 currently totals 448.480 doses and is part of the 3.852.000 doses of AstraZeneca that Indonesia received on April 26, 2021, through the Covax Facility / WHO scheme.
This batch has been distributed to the army and partly to Jakarta and North Sulawesi.
“The use of the AstraZeneca vaccine continues because the Covid-19 vaccination brings greater benefits,” said Siti Nadia.
Until now, based on Komnas KIPI data, there has never been an incident of people dying as a result of the Covid-19 vaccination in Indonesia.
In several previous cases, the death of people whose status had been vaccinated against Covid-19 was due to other causes, not the result of the vaccinations they received.
Regarding the report of serious post-immunization follow-up (AEFI) which is suspected to be related to AstraZeneca Batch CTMAV547, the National Commission on Post-Immunization Follow-Up Events (Komnas KIPI) has recommended Agency for Drug and Food Control to carry out sterility and toxicity tests on these groups due to insufficient data to diagnose the cause.
The written statement also ensures that the AstraZeneca Batches other than CTMAV547 are safe to use so that the public does not need to hesitate.